Paper published in a journal (Scientific congresses and symposiums)
Extended safety observations from denosumab administration in postmenopausal women from FREEDOM and FREEDOM extension trials
Brown, J. P.; Bone, H. G.; Chapurlat, R. et al.
2011In Arthritis and Rheumatism, 63 (S10), p. 431-432
Peer Reviewed verified by ORBi
 

Files


Full Text
Extended Safety Observations From Denosumab Administration in Postmenopausal Women From the FREEDOM and FREEDOM Extension Trials.pdf
Publisher postprint (104.16 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
General & internal medicine
Author, co-author :
Brown, J. P.
Bone, H. G.
Chapurlat, R.
Libanati, C.
Brandi, M. L.
Czerwinski, E.
Krieg, M. A.
Man, Z.
Mellstrom, D.
Radominski, S. C.
Reginster, Jean-Yves  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Resch, H.
Roman Ivorra, J. A.
Roux, C.
Daizadeh, N. S.
Grauer, A.
Cummings, S. R.
Papapoulos, S.
More authors (8 more) Less
Language :
English
Title :
Extended safety observations from denosumab administration in postmenopausal women from FREEDOM and FREEDOM extension trials
Publication date :
2011
Event name :
Vertex announces presentation of new data for oral JAK3 inhibitor VX-509
Event organizer :
Business Wire - Vertex Pharmaceuticals Incorporated
Event place :
Chicago, United States
Event date :
novembre 2011
Audience :
International
Journal title :
Arthritis and Rheumatism
ISSN :
0004-3591
eISSN :
1529-0131
Publisher :
Wiley Liss, Inc., New York, United States - New York
Volume :
63
Issue :
S10
Pages :
431-432
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 25 November 2011

Statistics


Number of views
50 (3 by ULiège)
Number of downloads
0 (0 by ULiège)

Bibliography


Similar publications



Contact ORBi